Zhi‐Jun Sun

16.0k total citations · 7 hit papers
311 papers, 12.6k citations indexed

About

Zhi‐Jun Sun is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Zhi‐Jun Sun has authored 311 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Molecular Biology, 116 papers in Oncology and 106 papers in Immunology. Recurrent topics in Zhi‐Jun Sun's work include Nanoplatforms for cancer theranostics (56 papers), Cancer Immunotherapy and Biomarkers (54 papers) and Immune cells in cancer (43 papers). Zhi‐Jun Sun is often cited by papers focused on Nanoplatforms for cancer theranostics (56 papers), Cancer Immunotherapy and Biomarkers (54 papers) and Immune cells in cancer (43 papers). Zhi‐Jun Sun collaborates with scholars based in China, United States and Hong Kong. Zhi‐Jun Sun's co-authors include Wen‐Feng Zhang, Lin‐Lin Bu, Yuan‐Tong Liu, Guang‐Tao Yu, Liang Mao, Qi‐Chao Yang, Lang Rao, Lei Wu, Wei‐Wei Deng and Wei Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

Zhi‐Jun Sun

300 papers receiving 12.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Turning cold tumors into hot tumors by improving T-cell infiltration

2021 533 citations Yuan‐Tong Liu, Zhi‐Jun Sun Theranostics profile →
Cancer Cell Membrane‐Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging

2016 475 citations Lin‐Lin Bu, Wen‐Feng Zhang et al. Advanced Materials profile →
Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance

2015 431 citations Lin‐Lin Bu, Guang‐Tao Yu et al. profile →
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis

2020 307 citations Lei Wu, Zhi‐Jun Sun et al. profile →
Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy

2021 266 citations Yao Xiao, Qi‐Chao Yang et al. profile →
Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy

2023 143 citations Liang Zhang, Qi‐Chao Yang et al. profile →
Cuproptosis: Harnessing Transition Metal for Cancer Therapy

2023 127 citations Yueying Huang, Zhi‐Jun Sun et al. profile →

Peers

Countries citing papers authored by Zhi‐Jun Sun

Since Specialization

Citations

This map shows the geographic impact of Zhi‐Jun Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Jun Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Jun Sun more than expected).

Fields of papers citing papers by Zhi‐Jun Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi‐Jun Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Jun Sun. The network helps show where Zhi‐Jun Sun may publish in the future.

Co-authorship network of co-authors of Zhi‐Jun Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi‐Jun Sun. A scholar is included among the top collaborators of Zhi‐Jun Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi‐Jun Sun. Zhi‐Jun Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dissecting Tertiary Lymphoid Structures in Cancer: Maturation, Localization and Density 2025 ·Theranostics ·(unknown), (unknown), Hao Li, Zhi‐Jun Sun	0
2	Radiotherapy elicits immunogenic cell death and metabolic shifts in the tumor microenvironment: implications for immunotherapy 2025 ·International Journal of Medical Sciences ·(unknown), Yueying Huang, (unknown), Zhi‐Jun Sun	3
3	Harnessing nanomaterials for copper-induced cell death 2024 ·Biomaterials ·Su-Ran Li, (unknown), (unknown), Chuanyu Hu, Zhi‐Jun Sun	14
4	Mitochondrial targeted nanomaterials for alleviating inflammation 2024 ·Nano Today ·(unknown), Wenda Wang, (unknown), Zhi‐Jun Sun, Lu Zhang	7
5	Harnessing cerium-based biomaterials for the treatment of bone diseases 2024 ·Acta Biomaterialia ·Xiang Meng, (unknown), Su-Ran Li, Zhi‐Jun Sun, Lu Zhang	15
6	A Poly‐prodrug Nanosphere for Modulating Janus‐faced Nature of Pyroptosis to Launch an Immune Offensive and Defensive Warfare Reigniting the Cancer‐immunity Cycle 2024 ·Advanced Functional Materials ·(unknown), (unknown), (unknown), Shanshan Zhang, (unknown), Hengbo Zhang, (unknown), Xiaoli Zhang, Zhi‐Jun Sun, Zhigang Xu	4
7	Establishment and verification of a nomogram that predicts the risk for coronary slow flow 2024 ·Frontiers in Endocrinology ·(unknown), (unknown), Dan Yi, Cheng‐Yu Yang, (unknown), Sibin Wang, Hao Li, (unknown), Zhi‐Jun Sun, Zhengbo Zhang, (unknown)	0
8	Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activity 2023 ·Molecular Therapy — Oncolytics ·(unknown), Shaowei Wang, (unknown), Ming Gao, (unknown), Liting Zhang, Dongli Pan, Qingsong Qin, (unknown), Ke Lan, Zhi‐Jun Sun, Junjie Zhang	5
9	CTLA-4 blockade induces tumor pyroptosis via CD8+ T cells in head and neck squamous cell carcinoma 2023 ·Molecular Therapy ·Shuo Wang, Zhi‐Zhong Wu, (unknown), Shu‐Cheng Wan, Mengjie Zhang, Boxin Zhang, Qi‐Chao Yang, Yao Xiao, Hao Li, Liang Mao, Zhiyong Wang, J. Silvio Gutkind, Zhi‐Jun Sun	35
10	Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma 2023 ·Cancer Letters ·Boxin Zhang, Hao Li, Yuan‐Tong Liu, Dian Xiong, Lu Zhang, Zhi‐Jun Sun	16
11	Deep learning‐assisted diagnosis of parotid gland tumors by using contrast‐enhanced CT imaging 2022 ·Oral Diseases ·(unknown), (unknown), Zhiyi Yang, (unknown), (unknown), Yongchao Xu, Zhi‐Jun Sun	11
12	Expression of HHLA2, TMIGD2, and GITR in salivary gland adenoid cystic carcinoma and mucoepidermoid carcinoma 2022 ·Journal of Oral Pathology and Medicine ·(unknown), Shuo Wang, Cong‐Cong Wu, (unknown), Zhi‐Jun Sun	1
13	Overexpression of CD168 is related to poor prognosis in oral squamous cell carcinoma 2021 ·Oral Diseases ·(unknown), Shuo Wang, Zhi‐Zhong Wu, Qi‐Chao Yang, (unknown), Shu‐Cheng Wan, Zhi‐Jun Sun	15
14	Overexpression of LAG3, TIM3, and A2aR in adenoid cystic carcinoma and mucoepidermoid carcinoma 2021 ·Oral Diseases ·(unknown), Cong‐Cong Wu, Shuo Wang, Leilei Yang, Zhi‐Jun Sun	2
15	Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges 2021 ·Cancer Communications ·Shu‐Jin Li, (unknown), Zhi‐Jun Sun	54
16	Engineering Multienzyme‐Mimicking Covalent Organic Frameworks as Pyroptosis Inducers for Boosting Antitumor Immunity 2021 ·Advanced Materials ·Liang Zhang, Qi‐Chao Yang, Shuo Wang, Yao Xiao, Shu‐Cheng Wan, Hexiang Deng, Zhi‐Jun Sun	159
17	Overexpression of RRM2 is related to poor prognosis in oral squamous cell carcinoma 2020 ·Oral Diseases ·Shuo Wang, Xiaolong Wang, Zhi‐Zhong Wu, Qi‐Chao Yang, Hong‐Gang Xiong, Yao Xiao, Hao Li, Zhi‐Jun Sun	30
18	Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma 2019 ·Cancer Immunology Research ·Lei Wu, Liang Mao, Jianfeng Liu, Lei Chen, Guang‐Tao Yu, Leilei Yang, Hao Wu, Lin‐Lin Bu, Ashok B. Kulkarni, Wen‐Feng Zhang, Zhi‐Jun Sun	164
19	Targeting CMTM6 Suppresses Stem Cell–Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma 2019 ·Cancer Immunology Research ·Lei Chen, Qi‐Chao Yang, Yicun Li, Leilei Yang, Jianfeng Liu, Hao Li, Yao Xiao, Lin‐Lin Bu, Wen‐Feng Zhang, Zhi‐Jun Sun	105
20	Chemopreventive and Chemotherapeutic Actions of mTOR Inhibitor in Genetically Defined Head and Neck Squamous Cell Carcinoma Mouse Model 2012 ·Clinical Cancer Research ·Zhi‐Jun Sun, Lu Zhang, Bradford Hall, Yansong Bian, J. Silvio Gutkind, Ashok B. Kulkarni	93

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact